Skip to main content

Table 1 Characteristics of study participants used for prediction

From: Predictors of remission from body dysmorphic disorder after internet-delivered cognitive behavior therapy: a machine learning approach

Variable

No. (%)

Sociodemographic variables

Gender

  Female*

74 (84%)

  Male*

14 (16%)

 Age, mean (SD)*

32.48 (11.62)

Household structure

  Married*

14 (16%)

  Have children*

33 (38%)

Level of education

  Primary school*

11 (12%)

  Secondary school*

50 (57%)

  University degree*

26 (30%)

  Doctorate

1 (1%)

Occupational status

  Working*

49 (56%)

  Student*

22 (25%)

  Unemployed*

13 (15%)

  Disability pension

1 (1%)

  Retired

3 (3%)

Clinical variables

 Years with BDD, mean (SD)*

18.83 (13.27)

Insight

  Good*

46 (52%)

  Poor*

34 (39%)

  Delusional*

8 (9%)

 No. body areas of concern, mean (SD)

7.67 (4.68)

Comorbidity

  Current depressive episode*

44 (50%)

  Panic disorder

3 (3%)

  Social anxiety disorder*

25 (28%)

  Obsessive-compulsive disorder*

8 (9%)

  Generalized anxiety disorder*

15 (17%)

  Bulimia nervosa

9 (10%)

  ADHD

2 (2%)

Medication

  SSRI*

12 (14%)

  SNRI

2 (2%)

  Other antidepressant*

7 (8%)

Previous treatment

  Cognitive behavioral therapy for BDD*

10 (11%)

  Other psychological treatment*

53 (60%)

  Previous contact with psychiatry*

54 (61%)

  Plastic surgery*

21 (24%)

  No. of plastic surgeries, mean (SD)*

0.56 (1.30)

Baseline measurements

CGI-Severity

  2 - Borderline mentally ill

3 (3%)

  3 - Mildly ill*

13 (15%)

  4 - Moderately ill*

47 (53%)

  5 - Markedly ill*

21 (24%)

  6 - Severely ill

3 (3%)

  7 - Among the most extremely ill patients

1 (1%)

GAF, mean (SD)*

56.24 (6.67)

BDD-YBOCS, mean (SD)*

27.74 (5.52)

EQ-5D, mean (SD)*

13.06 (3.55)

MADRS-S, mean (SD)*

18.92 (9.05)

Treatment-related variables

 Treatment credibility, mean (SD)*

31.59 (11.51)

 Working alliance inventory, mean (SD)*

65.27 (13.15)

 No. modules completed, mean (SD)*

6.25 (2.45)

Time spent on treatment (per week)

  1 h*

16 (18%)

  2 h*

17 (19%)

  3 h*

15 (17%)

  4 h*

6 (7%)

  5 h*

6 (7%)

  6 h*

8 (9%)

  7 h

3 (3%)

  8 h

5 (6%)

  9 h or more*

12 (14%)

Outcome: Number of participants in remission

 Post treatment

27 (31%)

 3-month follow-up

37 (42%)

 12-month follow-up

41 (47%)

 24-month follow-up

53 (60%)

  1. Abbreviations: BDD Body dysmorphic disorder, ADHD Attention deficit hyperactivity disorder, SSRI Selective serotonin reuptake inhibitor; SNRI Serotonin-norepinephrine reuptake inhibitor, CGI Clinical global impression scale, GAF Global assessment of functioning, BDD-YBOCS Yale-Brown obsessive compulsive scale modified for BDD, EQ-5D EuroQol 5-dimensions, MADRS-S Montgomery-Åsberg depression rating scale-self report
  2. *Variable was used in prediction